1. Butler, Christopher, Dunmire, Morgan, Choi, Jaebok, Walter, Matthew J, Liu, Tuoen. 2024. HSPA9/mortalin inhibition disrupts erythroid maturation through a TP53-dependent mechanism in human CD34+ hematopoietic progenitor cells. In Cell stress & chaperones, 29, 300-311. doi:10.1016/j.cstres.2024.03.006. https://pubmed.ncbi.nlm.nih.gov/38508444/
2. Gassié, Lionel, Lombard, Aude, Moraldi, Tiphanie, Marlier, Arnaud, Gilbert, Thierry. 2015. Hspa9 is required for pronephros specification and formation in Xenopus laevis. In Developmental dynamics : an official publication of the American Association of Anatomists, 244, 1538-49. doi:10.1002/dvdy.24344. https://pubmed.ncbi.nlm.nih.gov/26335666/
3. Younger, Georgianne, Vetrini, Francesco, Weaver, David D, Pratt, Victoria M, Torres-Martinez, Wilfredo. 2020. EVEN-PLUS syndrome: A case report with novel variants in HSPA9 and evidence of HSPA9 gene dysfunction. In American journal of medical genetics. Part A, 182, 2501-2507. doi:10.1002/ajmg.a.61808. https://pubmed.ncbi.nlm.nih.gov/32869452/
4. Zhou, Yong, Sun, Chao, Ma, Yingxu, Tu, Tao, Liu, Qiming. 2023. Identification and validation of aging-related genes in atrial fibrillation. In PloS one, 18, e0294282. doi:10.1371/journal.pone.0294282. https://pubmed.ncbi.nlm.nih.gov/37956134/
5. Guan, Yufeng, Zhu, Xianjun, Liang, Junjie, Huang, Shan, Pan, Xiaofen. 2021. Upregulation of HSPA1A/HSPA1B/HSPA7 and Downregulation of HSPA9 Were Related to Poor Survival in Colon Cancer. In Frontiers in oncology, 11, 749673. doi:10.3389/fonc.2021.749673. https://pubmed.ncbi.nlm.nih.gov/34765552/